DENDREON CORP (DNDN) 36.75 $0.74 (2.05%) 03:36PM (15 mins delay)

Dendreon Corp is the type of investment that will only grow with new discoveries. This discovery door has been opened with the FDA approval of a cancer drug that will drop the number of deaths due to...

Read complete stock pick on DNDN

1) FDA approval: DNDN's Provenge met and exceeded all FDA-stated requirements for approval. The most recent trial results constitute conclusive proof that Provenge works, and the FDA WILL approve the...

Read complete stock pick on DNDN

FDA is coming out on whther their prostate drug is approved or not in April. I strongly suggest that yu take a position on it before April 1st. The announcement will most likely occur before the market opens.

Read complete stock pick on DNDN

The accompanying table presents the top five rated companies with market caps of at least $250M from each of the 10 new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 500...

Read complete stock pick on DNDN

Prices went artificially high with the results of the trial. The drug is still not on the market

Read complete stock pick on DNDN